Jump Financial’s Regenxbio RGNX Stock Holding History

Jump Financial’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.87M	Buy	239,700 +18,911	+9%	+$157K	0.02%	745
2026 Q1	$1.85M	Buy	220,789 +42,764	+24%	+$449K	0.02%	683
2025 Q4	$2.56M	Buy	178,025 +128,025	+256%	+$1.6M	0.03%	584
2025 Q3	$483K	Buy	50,000 +19,576	+64%	+$173K	0.01%	1311
2025 Q2	$250K	Sell	30,424 -76,930	-72%	-$644K	﹤0.01%	1506
2025 Q1	$768K	Sell	107,354 -85,354	-44%	-$635K	0.01%	918
2024 Q4	$1.49M	Buy	192,708 +114,005	+145%	+$1.07M	0.03%	611
2024 Q3	$826K	Buy	78,703 +5,728	+8%	+$69.8K	0.02%	875
2024 Q2	$854K	Buy	+72,975	New	+$1.14M	0.02%	890
2024 Q1	–	Sell	-35,874	Closed	-$644K	–	2232
2023 Q4	$644K	Buy	+35,874	New	+$632K	0.02%	925
2023 Q3	–	Sell	-47,697	Closed	-$953K	–	2181
2023 Q2	$953K	Buy	+47,697	New	+$919K	0.04%	698
2022 Q2	–	Sell	-32,600	Closed	-$1.08M	–	1962
2022 Q1	$1.08M	Buy	+32,600	New	+$906K	0.05%	498
2021 Q4	–	Sell	-15,073	Closed	-$632K	–	1656
2021 Q3	$632K	Buy	+15,073	New	+$542K	0.05%	419

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jump Financial's RGNX Position: Q2 2026 in Review

Jump Financial increased its Regenxbio (RGNX) stake by 8.6% in Q2 2026, buying an estimated $157K and bringing the position to 239,700 shares worth $2.87M. The position accounts for 0.02% of the portfolio, ranked #745.

Jump Financial first reported a position in RGNX in Q3 2021 and has held it in 13 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

Jump Financial held 239,700 shares of Regenxbio worth $2.87M as of Q2 2026.
Jump Financial bought 18,911 Regenxbio shares in Q2 2026, an estimated $157K.
Regenxbio made up 0.02% of Jump Financial's portfolio in Q2 2026, its #745 holding.
Jump Financial first reported a position in Regenxbio in Q3 2021 and has held it in 13 quarters since.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.